首页|期刊导航|癌症生物学与医学(英文版)|Mechanisms underlying prostate cancer sensitivity to reactive oxygen species:overcoming radiotherapy resistance and recent clinical advances
癌症生物学与医学(英文版)2025,Vol.22Issue(7):747-761,15.DOI:10.20892/j.issn.2095-3941.2024.0584
Mechanisms underlying prostate cancer sensitivity to reactive oxygen species:overcoming radiotherapy resistance and recent clinical advances
Mechanisms underlying prostate cancer sensitivity to reactive oxygen species:overcoming radiotherapy resistance and recent clinical advances
摘要
关键词
Prostate cancer(PCa)/radiation therapy(RT)/reactive oxygen species(ROS)/radiotherapy resistance/antioxidantsKey words
Prostate cancer(PCa)/radiation therapy(RT)/reactive oxygen species(ROS)/radiotherapy resistance/antioxidants引用本文复制引用
Meidan Wang,Rui Xing,Liqun Wang,Mingyue Pan,Ruoyun Zhang,Ting Li,Weiqiang Sun,Jing Zhou..Mechanisms underlying prostate cancer sensitivity to reactive oxygen species:overcoming radiotherapy resistance and recent clinical advances[J].癌症生物学与医学(英文版),2025,22(7):747-761,15.基金项目
This study was supported by grants from Ningbo Yongjiang Talent programme-Project for Innovative Talents(Grant No.20240340),Jinhua Science and Technology Bureau(Grant No.2022-4-258),and 2022 Shandong Medical Association Clinical Research Special Fund for Dynamic Monitoring of Lymphocyte Subpopulations by Flow Cytometry(Grant No.YXH2022ZX03227). (Grant No.20240340)